The Securities and Exchange Commission is reportedly investigating the circumstances around Eastman Kodak’s announcement of a $765 million government loan to make drugs at its U.S.
factories. News of the loan last week caused Kodak’s shares to rise as high as $60, briefly producing a potential windfall for company executives. The investigation is at an
early stage and might not produce allegations of wrongdoing by the company or any individuals. At a White House briefing Tuesday night, President Trump distanced himself from the Kodak deal, saying he
wasn’t involved.
Read the whole story at The Wall Street Journal »
